Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CBNA - US15746L1008 - Common Stock

38.22 USD
+0.37 (+0.98%)
Last: 12/19/2025, 8:04:00 PM
38.22 USD
0 (0%)
After Hours: 12/19/2025, 8:04:00 PM
Fundamental Rating

3

Overall CBNA gets a fundamental rating of 3 out of 10. We evaluated CBNA against 388 industry peers in the Banks industry. The financial health of CBNA is average, but there are quite some concerns on its profitability. CBNA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CBNA was profitable.
In the past year CBNA had a positive cash flow from operations.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

The Return On Assets of CBNA (1.21%) is better than 77.06% of its industry peers.
CBNA has a better Return On Equity (11.42%) than 77.58% of its industry peers.
Industry RankSector Rank
ROA 1.21%
ROE 11.42%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 35.24%, CBNA belongs to the top of the industry, outperforming 92.01% of the companies in the same industry.
CBNA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 35.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBNA has more shares outstanding
There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC9.89%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 132.05% over the past year.
Looking at the last year, CBNA shows a very strong growth in Revenue. The Revenue has grown by 70.68%.
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.1%
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.36%

3.2 Future

CBNA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.42% yearly.
Based on estimates for the next years, CBNA will show a small growth in Revenue. The Revenue will grow by 7.57% on average per year.
EPS Next Y-28.83%
EPS Next 2Y-4.42%
EPS Next 3Y-9.42%
EPS Next 5YN/A
Revenue Next Year7.67%
Revenue Next 2Y13.78%
Revenue Next 3Y7.57%
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20M 40M 60M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.36 indicates a correct valuation of CBNA.
CBNA's Price/Earnings ratio is in line with the industry average.
CBNA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.39.
With a Price/Forward Earnings ratio of 9.67, the valuation of CBNA can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBNA indicates a somewhat cheap valuation: CBNA is cheaper than 66.49% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CBNA to the average of the S&P500 Index (23.84), we can say CBNA is valued rather cheaply.
Industry RankSector Rank
PE 13.36
Fwd PE 9.67
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

74.23% of the companies in the same industry are cheaper than CBNA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.67
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CBNA's earnings are expected to decrease with -9.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.42%
EPS Next 3Y-9.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CBNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (12/19/2025, 8:04:00 PM)

After market: 38.22 0 (0%)

38.22

+0.37 (+0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)01-26 2026-01-26
Inst Owners50.76%
Inst Owner Change7.55%
Ins Owners25.35%
Ins Owner Change72.39%
Market Cap250.72M
Revenue(TTM)52.87M
Net Income(TTM)18.63M
Analysts80
Price Target34.68 (-9.26%)
Short Float %1.47%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-2.86%
Max EPS beat(2)30.3%
EPS beat(4)3
Avg EPS beat(4)21.5%
Min EPS beat(4)-2.86%
Max EPS beat(4)53.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.87%
Min Revenue beat(2)0.96%
Max Revenue beat(2)6.78%
Revenue beat(4)4
Avg Revenue beat(4)12%
Min Revenue beat(4)0.96%
Max Revenue beat(4)25.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.37%
PT rev (3m)13.33%
EPS NQ rev (1m)-5.02%
EPS NQ rev (3m)-3.81%
EPS NY rev (1m)-1.74%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)-2.88%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)1.43%
Valuation
Industry RankSector Rank
PE 13.36
Fwd PE 9.67
P/S 4.74
P/FCF 23.67
P/OCF 18.55
P/B 1.54
P/tB 1.54
EV/EBITDA N/A
EPS(TTM)2.86
EY7.48%
EPS(NY)3.95
Fwd EY10.35%
FCF(TTM)1.61
FCFY4.22%
OCF(TTM)2.06
OCFY5.39%
SpS8.06
BVpS24.86
TBVpS24.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 11.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.24%
GM N/A
FCFM 20.03%
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 614.92%
Cap/Sales 5.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 56.85%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC9.89%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.1%
EPS Next Y-28.83%
EPS Next 2Y-4.42%
EPS Next 3Y-9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.36%
Revenue Next Year7.67%
Revenue Next 2Y13.78%
Revenue Next 3Y7.57%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A

CHAIN BRIDGE BANCORP INC-A / CBNA FAQ

Can you provide the ChartMill fundamental rating for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a fundamental rating of 3 / 10 to CBNA.


Can you provide the valuation status for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a valuation rating of 3 / 10 to CHAIN BRIDGE BANCORP INC-A (CBNA). This can be considered as Overvalued.


How profitable is CHAIN BRIDGE BANCORP INC-A (CBNA) stock?

CHAIN BRIDGE BANCORP INC-A (CBNA) has a profitability rating of 2 / 10.


Can you provide the financial health for CBNA stock?

The financial health rating of CHAIN BRIDGE BANCORP INC-A (CBNA) is 4 / 10.


Can you provide the expected EPS growth for CBNA stock?

The Earnings per Share (EPS) of CHAIN BRIDGE BANCORP INC-A (CBNA) is expected to decline by -28.83% in the next year.